Stephen H. Rusckowski
CIK: 0001142624
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Sep 29, 2026ORCL
ORACLE CORP
Purchase(P)Indirect25K shares at avg. $139.35$3.5M - May 31, 2026ORCL
ORACLE CORP
Award(A)DirectRestricted Stock Unit
1.6K shares- - Nov 18, 2025ORCL
ORACLE CORP
Award(A)DirectRestricted Stock Unit
793 shares- - May 23, 2025THC
TENET HEALTHCARE CORP
Exercise(M)Direct1.6K shares- - May 22, 2025THC
TENET HEALTHCARE CORP
Award(A)DirectRestricted Stock Units
1.3K shares- - May 6, 2025BAX
BAXTER INTERNATIONAL INC
Award(A)Direct7.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 29, 2026 | ORCL ORACLE CORP | Purchase(P) | 25,000 | $139.35 | $3,483,800 | Indirect |
| May 31, 2026 | ORCL ORACLE CORP | Award(A) Restricted Stock Unit | 1,550 | - | - | Direct |
| Nov 18, 2025 | ORCL ORACLE CORP | Award(A) Restricted Stock Unit | 793 | - | - | Direct |
| May 23, 2025 | THC TENET HEALTHCARE CORP | Exercise(M) | 1,551 | - | - | Direct |
| May 22, 2025 | THC TENET HEALTHCARE CORP | Award(A) Restricted Stock Units | 1,333 | - | - | Direct |
| May 6, 2025 | BAX BAXTER INTERNATIONAL INC | Award(A) | 7,183 | - | - | Direct |
1-6 of 6 transactions
About RUSCKOWSKI STEPHEN H
RUSCKOWSKI STEPHEN H (SEC CIK 0001142624) files insider reports with the SEC as Director of ORACLE CORP (ORCL), Director of TENET HEALTHCARE CORP (THC) and Director of BAXTER INTERNATIONAL INC (BAX).
Signal8 holds 6 ownership filings by RUSCKOWSKI STEPHEN H (1 Form 3, 5 Form 4), filed between May 8, 2025 and Oct 1, 2026. Those filings report 6 transactions, from May 6, 2025 to Sep 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on RUSCKOWSKI STEPHEN H's filings is in RENO, NV.
Recent filings by RUSCKOWSKI STEPHEN H
- Sep 29, 2026: Open-market purchase of ORCL shares (Form 4, code P).
- May 31, 2026: Grant or award of ORCL derivative securities (Form 4, code A).
- Nov 18, 2025: Grant or award of ORCL derivative securities (Form 4, code A).
- May 23, 2025: Option exercise of THC shares (Form 4, code M).
- May 22, 2025: Grant or award of THC derivative securities (Form 4, code A).
Other insiders filing for ORACLE CORP (ORCL)
- Smith Maria, EVP, Chief Accounting Officer
- HENLEY JEFFREY, Vice Chairman
- CATZ SAFRA, Chief Executive Officer
- Levey Stuart, EVP, Chief Legal Officer
- Sicilia Michael D., Chief Executive Officer
- Maxson Hilary B, Chief Financial Officer